Literature DB >> 10698590

Experience with insulin-like growth factor I (IGF-I) treatment of growth hormone insensitivity syndrome (GHIS).

M B Ranke1, H A Wollmann, M O Savage.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10698590

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


× No keyword cloud information.
  3 in total

Review 1.  Clinical use of somatomedin-1: yes or no?

Authors:  Z Laron
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

2.  Managing idiopathic short stature: role of somatropin (rDNA origin) for injection.

Authors:  J Paul Frindik; Stephen F Kemp
Journal:  Biologics       Date:  2010-06-24

3.  IGF-I improved bone mineral density and body composition of weaver mutant mice.

Authors:  Weiguo Yao; Jin Zhong; Jun Yu; Therry Warner; Tomica Bozic; Ping Ye; A Joseph D'Ercole; Janet M Hock; Wei-Hua Lee
Journal:  Growth Horm IGF Res       Date:  2008-06-11       Impact factor: 2.372

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.